KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Other Working Capital Changes (2016 - 2025)

CareDx (CDNA) has disclosed Other Working Capital Changes for 13 consecutive years, with -$3.9 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 551.16% to -$3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.4 million through Dec 2025, up 828.22% year-over-year, with the annual reading at $4.4 million for FY2025, 828.22% up from the prior year.
  • Other Working Capital Changes hit -$3.9 million in Q4 2025 for CareDx, down from $4.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $6.8 million in Q4 2021 to a low of -$5.9 million in Q3 2021.
  • Historically, Other Working Capital Changes has averaged $186400.0 across 5 years, with a median of -$80500.0 in 2022.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 36850.0% in 2021 and later soared 2677.78% in 2025.
  • Year by year, Other Working Capital Changes stood at $6.8 million in 2021, then tumbled by 115.63% to -$1.1 million in 2022, then soared by 172.7% to $775000.0 in 2023, then tumbled by 178.19% to -$606000.0 in 2024, then tumbled by 551.16% to -$3.9 million in 2025.
  • Business Quant data shows Other Working Capital Changes for CDNA at -$3.9 million in Q4 2025, $4.2 million in Q3 2025, and $1.4 million in Q2 2025.